STOCK TITAN

September 2022 Stock Gainers on News

Ranked by the close-to-close change of the trading session each announcement landed in. How this is measured.

Data as of the trading session of , 21 of 21 completed market sessions produced ranked moves. That date is the last ranked session, not the last priced one, so follow-through dates run later.

On 100 of these rows the measured session was reconstructed from the announcement time, because it predates our stored session records.

See the biggest losers of September 2022 Every stock ranked by its September 2022 gain, with or without news

100

Ranked gains

+167.74%

Largest, SPRO

86.9%

Above baseline, day +5

2.0%

Median give-back, day +5

Filter and sort
Rows

100 ranked gains in September 2022

Skip the ranked rows and go to the month summary

Every percentage on a row, the follow-through readings included, is measured against that row's own pre-news close, which the row names. A day +5 reading is therefore the move from before the announcement, not a further change on top of the headline percentage.

Rows are ordered by the move measured when the board was ranked. A percentage recomputed from the session's own closing prices can sit a little above or below its neighbours; the rank is the one the measured move gave the row.

Rank Symbol close to close Session Catalyst Announcement
1 SPRO More than one ranked move this month 2+ ranked moves +167.74% against the close of 09/21/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership GSK and Spero Therapeutics Announce Exclusive License Agreement for Late-Stage Antibiotic Asset, Tebipenem HBr

02:00 ET premarket

2 AKRO +136.76% against the close of 09/12/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results In Akero Therapeutics’ Phase 2b HARMONY Study, Both the 50mg and 28mg EFX Doses Achieved Statistical Significance on Primary and Secondary Histology Endpoints after 24 Weeks

06:00 ET premarket

3 PEPG +110.19% against the close of 09/27/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results PepGen Reports Positive Data from Phase 1 Trial of PGN-EDO51 for the Treatment of Duchenne Muscular Dystrophy

06:00 ET premarket

4 LVTX +97.50% against the close of 09/23/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Seagen and LAVA Therapeutics Announce Exclusive Worldwide License Agreement to Advance LAVA-1223, a Preclinical Gamma Delta Bispecific T Cell Engager for EGFR-Expressing Solid Tumors

08:00 ET premarket

5 SLNG +73.67% against the close of 09/20/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Stabilis Solutions Receives DOE Approval to Export LNG

08:00 ET premarket

6 DMS +71.88% against the close of 09/08/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement DMS Receives Non-Binding “Go Private” Proposal

16:15 ET after hours

7 ISEE +66.31% against the close of 09/02/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Iveric Bio Announces Positive Topline Data from Zimura® GATHER2 Phase 3 Clinical Trial in Geographic Atrophy

06:00 ET premarket

8 BTRS +60.83% against the close of 09/27/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition Billtrust to be Acquired by EQT Private Equity for Equity Value of $1.7 Billion

09:00 ET premarket

9 PYPD Also on the opposite board this month on both boards +58.33% against the close of 09/09/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results PolyPid Announces Presentation of Phase 2 D-PLEX₁₀₀ Clinical Data at the European Society for Coloproctology Scientific Conference

07:00 ET premarket

10 SPRO More than one ranked move this month 2+ ranked moves +55.50% against the close of 09/02/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Spero Therapeutics Provides Tebipenem HBr Program Update Following Type A Meeting with the U.S. Food and Drug Administration

08:05 ET premarket

11 ECOM +55.03% against the close of 09/02/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition CommerceHub to Acquire ChannelAdvisor for $23.10 per share

07:30 ET premarket

12 FMTX +51.04% against the close of 08/31/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition Novo Nordisk to acquire Forma Therapeutics and expand presence in sickle cell disease and rare blood disorders

08:00 ET premarket

13 AMLX Also on the opposite board this month on both boards +51.01% against the close of 09/07/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
FDA & Regulatory Amylyx Pharmaceuticals Announces FDA Advisory Committee Supports Approval of AMX0035 for the Treatment of ALS

19:45 ET after hours

14 AAOI +50.40% against the close of 09/15/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition Applied Optoelectronics Announces Definitive Agreement to Sell its Chinese Manufacturing Facilities and Certain Assets Related to its Transceiver Business for $150 Million

16:10 ET after hours

15 XFOR +40.18% against the close of 09/26/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results X4 Pharmaceuticals Announces New Positive Phase 1b Data Supporting Mavorixafor’s Broad Potential in Chronic Neutropenia (CN)

07:50 ET premarket

16 BIIB +39.85% against the close of 09/27/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results LECANEMAB CONFIRMATORY PHASE 3 CLARITY AD STUDY MET PRIMARY ENDPOINT, SHOWING HIGHLY STATISTICALLY SIGNIFICANT REDUCTION OF CLINICAL DECLINE IN LARGE GLOBAL CLINICAL STUDY OF 1,795 PARTICIPANTS WITH EARLY ALZHEIMER'S DISEASE

19:30 ET after hours

17 ATHX +39.32% against the close of 09/22/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Rose on dilution Athersys Amends Securities Purchase Agreement in Connection with Recent Registered Direct Offering

09:19 ET premarket

18 LITM Also on the opposite board this month on both boards +38.26% against the close of 09/22/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Snow Lake Lithium and LG Energy Solution Collaborate To Establish Lithium Supply Chain in North America

06:00 ET premarket

19 GROV +35.47% against the close of 09/26/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Grove Co. Continues Retail Expansion with Entry Into Thousands of More Stores

08:31 ET premarket

20 CO +34.58% against the close of 09/22/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement The Grand Court of the Cayman Islands Granted Blue Ocean’s Application to Appoint Joint Provisional Liquidators for Global Cord Blood Corporation

13:52 ET intraday

21 IDYA +30.70% against the close of 09/09/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results IDEAYA Reports Positive Interim Phase 2 Clinical Results for Darovasertib and Crizotinib Synthetic Lethal Combination in Metastatic Uveal Melanoma

17:00 ET after hours

22 KLXE +30.28% against the close of 09/27/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement KLX Energy Services Announces Amendment and Extension of ABL Facility

08:00 ET premarket

23 BBAI +30.25% against the close of 09/28/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership BigBear.ai Awarded $14.8 Million U.S. Army Global Force Information Management System Contract

08:00 ET premarket

24 OIIM +30.15% against the close of 09/29/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership O2Micro Enters into Definitive Agreement for “Going Private” Transaction

09:35 ET intraday

25 NTNX +29.13% against the close of 08/31/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Nutanix Reports Fourth Quarter and Fiscal 2022 Financial Results

16:05 ET after hours

26 KNBE +28.15% against the close of 09/16/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement KnowBe4 Confirms Receipt of Non-Binding Proposal from Vista Equity Partners

09:20 ET premarket

27 AKUS +28.00% against the close of 09/12/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
FDA & Regulatory Akouos Receives FDA Clearance of its IND Application for AK-OTOF, a Gene Therapy Intended for the Treatment of OTOF-mediated Hearing Loss

07:00 ET premarket

28 HROW More than one ranked move this month 2+ ranked moves +27.86% against the close of 09/26/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
FDA & Regulatory Harrow Announces U.S. FDA Approval of IHEEZO™ (Chloroprocaine Hydrochloride Ophthalmic Gel) 3% for Ocular Surface Anesthesia

13:50 ET intraday

29 ALLK +27.51% against the close of 09/16/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Rose on dilution Allakos Announces Pricing of $150 Million Underwritten Offering of Common Stock

07:00 ET premarket

30 SPRO More than one ranked move this month 2+ ranked moves +26.55% against the close of 09/06/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Spero Therapeutics to Present at Upcoming Investor Conference

08:05 ET premarket

31 AVCO +25.85% against the close of 09/28/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Avalon GloboCare Receives Allowance for Joint U.S. Patent

09:00 ET premarket

32 LFST +25.76% against the close of 09/07/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Leadership Change LifeStance Health Appoints Ken Burdick as CEO and Chairman; Founding CEO and Chairman Michael Lester Retires

09:00 ET premarket

33 ASAN More than one ranked move this month 2+ ranked moves +24.79% against the close of 09/07/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Rose on dilution Asana Announces $350 Million Private Placement

16:05 ET after hours

34 TWIN +24.62% against the close of 08/31/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Twin Disc, Inc. Announces Fiscal 2022 Fourth Quarter Financial Results

08:00 ET premarket

35 AKA +23.73% against the close of 09/06/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement a.k.a. Brands Holding Corp. Announces Participation in the Piper Sandler Growth Frontiers Conference

08:00 ET premarket

36 EQ +22.80% against the close of 09/26/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Equillium Announces Positive Interim Results from the EQUALISE Study in Subjects with Lupus Nephritis

07:00 ET premarket

37 EVAX +22.63% against the close of 09/20/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Important Milestone Reached for Evaxion Biotech’s EVX-01 Personalized Cancer Therapy

05:45 ET premarket

38 AVTX +22.29% against the close of 09/02/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Avalo Advances BTLA Agonist Fusion Protein (AVTX-008) to IND-enabling Stage

07:00 ET premarket

39 INNV +21.98% against the close of 09/13/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings InnovAge Announces Financial Results for the Fiscal Year and Fourth Quarter Ended June 30, 2022

16:05 ET after hours

40 ZS +21.88% against the close of 09/08/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Zscaler Reports Fourth Quarter and Fiscal 2022 Financial Results

16:05 ET after hours

41 RVNC +21.58% against the close of 09/07/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
FDA & Regulatory Revance Announces FDA Approval of DAXXIFY™ (DaxibotulinumtoxinA-lanm) for Injection, the First and Only Peptide-Formulated Neuromodulator With Long-Lasting Results

07:00 ET premarket

42 INPX +21.50% against the close of 09/23/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Reverse Merger / Shell Inpixon's Enterprise Apps Business to be Acquired in a Business Combination Transaction Valued at $69 Million

09:30 ET intraday

43 FUSN +21.09% against the close of 09/13/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Fusion Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

16:45 ET after hours

44 RETA +21.06% against the close of 09/06/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Reata Pharmaceuticals Announces Participation in the Citi 17th Annual BioPharma Conference

16:51 ET after hours

45 VNET +20.68% against the close of 09/12/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition VNET Announces Receipt of Preliminary Non-Binding Proposal to Acquire All of Its Shares and Formation of Special Committee to Review the Proposal

08:39 ET premarket

46 JUPW +20.53% against the close of 09/28/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Jupiter Wellness Announces Application for Dual Listing on Upstream

08:30 ET premarket

47 FRBK +20.08% against the close of 09/14/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement REPUBLIC FIRST BANCORP, INC. ANNOUNCES STRATEGIC REVIEW

09:00 ET premarket

48 EVEX Also on the opposite board this month on both boards +19.97% against the close of 09/07/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement United Invests Another $15 Million in Electric Flying Taxi Market with Eve

07:00 ET premarket

49 STOR +19.90% against the close of 09/14/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition STORE Capital to be Acquired by GIC and Oak Street in $14 Billion Transaction

08:00 ET premarket

50 PNT Also on the opposite board this month on both boards +19.84% against the close of 09/09/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results POINT Biopharma Provides Updated Efficacy and Safety Data from the Lead-In Cohort of the Phase 3 SPLASH Trial in mCRPC at ESMO Congress 2022

03:05 ET premarket

51 ALR +19.82% against the close of 09/16/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Leadership Change AlerisLife Announces the Appointment of Heather Pereira as Senior Vice President, Chief Financial Officer and Treasurer

08:05 ET premarket

52 TRT +19.61% against the close of 09/22/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Trio-Tech Reports Fiscal 2022 Net Income of $0.57 Per Share Versus a Loss of $0.15 Per Share as Revenue Increased 36%

08:30 ET premarket

53 HOWL +19.57% against the close of 08/31/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Werewolf Therapeutics Announces Initiation of Patient Dosing in Phase 1/1b Clinical Trial of WTX-124 for the Treatment of Patients with Selected Solid Tumors

07:00 ET premarket

54 AMRS +19.56% against the close of 09/06/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement AMYRIS TO PARTICIPATE AT SEPTEMBER INVESTOR CONFERENCES

08:00 ET premarket

55 EPM +19.44% against the close of 09/13/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Buyback / Dividend Evolution Petroleum Reports Fourth Quarter and Full Year Fiscal 2022 Results, Declares Increased Quarterly Cash Dividend for First Quarter Fiscal 2023, and Announces $25 Million Share Repurchase Program

16:15 ET after hours

56 AURA +19.23% against the close of 09/27/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Aura Biosciences Announces First Patient Dosed in Phase 1 Study Evaluating Belzupacap Sarotalocan (AU-011) for the Treatment of Non-Muscle Invasive Bladder Cancer

07:00 ET premarket

57 REGN +18.85% against the close of 09/07/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Aflibercept 8 mg Meets Primary Endpoints in Two Global Pivotal Trials for DME and wAMD, with a Vast Majority of Patients Maintained on 12- and 16-week Dosing Intervals

09:00 ET premarket

58 GKOS +18.52% against the close of 09/06/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Glaukos Announces Positive Topline Outcomes for Both Phase 3 Pivotal Trials of iDose TR, Achieving Primary Efficacy Endpoints and Demonstrating Favorable Tolerability and Safety Profiles

07:00 ET premarket

59 BLPH +18.43% against the close of 09/26/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
FDA & Regulatory Bellerophon Announces FDA Acceptance of Change to Ongoing Phase 3 REBUILD Study of INOpulse® for Treatment of Fibrotic Interstitial Lung Disease

08:30 ET premarket

60 PALI +18.33% against the close of 09/12/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Palisade Bio to Present at the Virtual Investor Innovations in Intestinal Health - Launching a Pivotal Phase 3 Study for Return of Postoperative Bowel Function Event

09:05 ET premarket

61 PLSE +18.30% against the close of 09/23/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
FDA & Regulatory Pulse Biosciences Announces FDA 510(k) Clearance for the Treatment of Sebaceous Hyperplasia

08:00 ET premarket

62 DYN +18.25% against the close of 09/06/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Dyne Therapeutics to Present at Morgan Stanley 20th Annual Global Healthcare Conference

16:30 ET after hours

63 CYTH +18.02% against the close of 09/27/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Cyclo Therapeutics Provides Business Update

14:02 ET intraday

64 COUP +17.91% against the close of 09/06/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Coupa Software Reports Second Quarter Fiscal 2023 Financial Results

16:03 ET after hours

65 CVV +17.58% against the close of 09/27/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership CVD Equipment Corporation Announces Sale and Leaseback Agreement

16:05 ET after hours

66 NUVL +17.55% against the close of 09/06/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Nuvalent to Present Preliminary Phase 1 Data from ARROS-1 Clinical Trial of NVL-520 at 34th EORTC-NCI-AACR Symposium and Announces Pipeline Updates

06:30 ET premarket

67 CDE +17.54% against the close of 09/16/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition Coeur Announces Agreement to Sell Southern Nevada Holdings for Upfront Cash Consideration of $150 million

06:50 ET premarket

68 CPTN +17.42% against the close of 09/20/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Cepton Adds Lidar Digital Twin to NVIDIA DRIVE Sim, Advancing the Development of Safe Autonomous Driving Technology

12:13 ET intraday

69 SHCR +17.37% against the close of 09/16/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership Sharecare awarded three-year NCQA Accreditation for Wellness and Health Promotion

07:30 ET premarket

70 USEA More than one ranked move this month 2+ ranked moves +17.36% against the close of 09/01/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Buyback / Dividend United Announces $3 million Share Buyback Plan

09:00 ET premarket

71 AMPS Also on the opposite board this month on both boards +17.10% against the close of 09/26/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition Altus Power, Inc. Announces Definitive Agreements to Acquire Approximately 97 Megawatts of Operating Solar Assets

07:37 ET premarket

72 MCRB +17.04% against the close of 09/06/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
FDA & Regulatory Seres Therapeutics Announces Completion of Rolling BLA Submission to FDA for Investigational Microbiome Therapeutic SER-109 for Recurrent C. Difficile Infection

07:00 ET premarket

73 FHS +16.95% against the close of 09/07/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings First High-School Education Group Announces First Half 2022 Unaudited Financial Results

07:30 ET premarket

74 TC +16.61% against the close of 09/29/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings TuanChe Announces Unaudited First Half 2022 Financial Results

17:00 ET after hours

75 ASAN More than one ranked move this month 2+ ranked moves +16.42% against the close of 09/09/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Asana to Present at Upcoming Investor Events

16:05 ET after hours

76 ADT +16.37% against the close of 09/02/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership ADT Announces Partnership With State Farm, Plans Innovative Offering That Combines Security, Risk Mitigation and Smart Home Capabilities to Revolutionize the Customer Experience

08:30 ET premarket

77 HROW More than one ranked move this month 2+ ranked moves +16.25% against the close of 09/28/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement ImprimisRx Launches Fortisite™ (Tobramycin 1.5% + Vancomycin 5%) Compounded Antibiotic Formulation

07:00 ET premarket

78 ANVS +15.65% against the close of 09/07/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Annovis Bio's CEO Maria Maccecchini Issues Letter to Stockholders

07:30 ET premarket

79 LRMR +15.56% against the close of 09/13/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
FDA & Regulatory Larimar Therapeutics Announces FDA Clearance to Initiate the 25 mg Cohort of a Phase 2 Dose Exploration Trial of CTI-1601 in Friedreich’s Ataxia Patients

07:01 ET premarket

80 PHR +15.55% against the close of 09/07/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Phreesia Announces Fiscal Second Quarter 2023 Results

16:03 ET after hours

81 RGLS More than one ranked move this month 2+ ranked moves +15.48% against the close of 09/09/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Regulus Therapeutics Announces Positive Topline Safety and Pharmacokinetic (PK) Data from the Phase 1 Single-Ascending Dose (SAD) Clinical Trial of RGLS8429 for the treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)

08:00 ET premarket

82 PL +15.45% against the close of 09/13/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership Planet Partners with Taylor Geospatial Institute, Data Expected To Be Leveraged for Research on Food Security and Defense and Intelligence

09:00 ET premarket

83 PETQ +15.21% against the close of 09/02/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Buyback / Dividend PetIQ, Inc. Announces $30 Million Stock Repurchase Program

08:00 ET premarket

84 USEA More than one ranked move this month 2+ ranked moves +15.13% against the close of 09/21/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Buyback / Dividend United Completes Stock Buyback of $3 million and Initiates Additional $3 million Stock Buyback Plan

09:00 ET premarket

85 IFRX +15.02% against the close of 09/07/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results InflaRx Announces Vilobelimab Phase III Results in Critically Ill COVID-19 Patients Published in The Lancet Respiratory Medicine

07:30 ET premarket

86 AVAV +14.89% against the close of 09/07/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings AeroVironment Announces Fiscal 2023 First Quarter Results

16:10 ET after hours

87 RCOR +14.74% against the close of 09/19/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition Rocket Pharmaceuticals to Acquire Renovacor, Extending Leadership in AAV-based Cardiac Gene Therapy

06:00 ET premarket

88 TERN +14.74% against the close of 09/07/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Terns Pharmaceuticals to Present at the H.C. Wainwright 24th Annual Global Investment Conference

16:05 ET after hours

89 QUIK +14.69% against the close of 09/07/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership QuickLogic Awarded a $6.9 Million Base Contract to Develop Strategic Radiation Hardened FPGA Technology

08:33 ET premarket

90 SIDU +14.66% against the close of 09/06/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Sidus Space Executes Multiple Launch Agreement with SpaceX

09:00 ET premarket

91 RYTM Also on the opposite board this month on both boards +14.38% against the close of 09/07/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Rhythm Pharmaceuticals Announces New Employment Inducement Grants

16:01 ET after hours

92 CIR +14.28% against the close of 09/29/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings CIRCOR Reports Financial Results for Second Quarter Ended July 3, 2022

06:15 ET premarket

93 GTLB +14.26% against the close of 09/06/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings GitLab Reports Second Quarter Fiscal Year 2023 Financial Results

16:05 ET after hours

94 CHG +14.11% against the close of 09/26/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings CorpHousing Group Inc. Announces 2022 Second Quarter Financial Results

16:25 ET after hours

95 RGLS More than one ranked move this month 2+ ranked moves +14.08% against the close of 09/02/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Regulus Therapeutics to Participate in Upcoming Investor Conferences

16:05 ET after hours

96 ASO +14.02% against the close of 09/06/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Academy Sports + Outdoors Reports Second Quarter 2022 Results

08:00 ET premarket

97 TRQ +13.94% against the close of 08/31/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition Turquoise Hill Announces Agreement in Principle with Rio Tinto for Transaction at C$43 per share in Cash

00:02 ET premarket

98 CGTX +13.79% against the close of 09/28/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Cognition Therapeutics to Participate in the 2022 Cantor Fitzgerald Neurology & Psychiatry Conference

07:30 ET premarket

99 ARBK +13.70% against the close of 09/08/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Crypto & Treasury Argo Blockchain PLC Announces August 2022 Operational Update

02:00 ET premarket

100 RCKT +13.68% against the close of 09/29/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Rocket Pharmaceuticals Announces Positive Updates from Phase 1 Clinical Trial for RP-A501 in Danon Disease at the Heart Failure Society of America (HFSA) Annual Scientific Meeting 2022

06:00 ET premarket

NYSE and Nasdaq companies with a market capitalization of $25M or more, measured today. The exchange is the one recorded on each announcement, and a release naming several tickers records one venue for all of them. A session that changed hands for less than $25,000 in total is not ranked, because a percentage set by a handful of shares is a print rather than a move. On a board older than a year a fund is identified by its name alone, because an instrument class describes whoever holds the ticker today. 634 smaller events this month are held out of this month's eligible pool; switch to include them. 225 events never entered this month's eligible pool, because the ticker is a warrant, a unit, a right or a preferred rather than common stock, or carries a stored capitalization above $10 trillion, which is larger than any company has reached. Include the $5M to $25M band

2 candidate events for this board could not be anchored to a trading session and are not listed.

1 event was left out of this board because the price series changes basis between the baseline close and the measured one, so the two prices do not describe the same shares of the same company and their ratio measures a corporate action, or a change in what the ticker identifies, rather than a move.

Company names are not shown on months older than a year, because only the current holder of each ticker is known.

In September 2022, the median gainer had given back 2.0% of its move five sessions later; the largest catalyst group was Other Announcement, 30 of the 100 events, at a median of +20.8%.

Close-to-close change on the measured trading session, against the previous close.

NYSE and Nasdaq companies with a market capitalization of $25M or more, measured today. The exchange is the one recorded on each announcement, and a release naming several tickers records one venue for all of them. A session that changed hands for less than $25,000 in total is not ranked, because a percentage set by a handful of shares is a print rather than a move. On a board older than a year a fund is identified by its name alone, because an instrument class describes whoever holds the ticker today.

Which catalysts drove the board

Swipe the table sideways for the day +5 columns.

Catalyst Events Share of board Median move close to close Median at day +5 Still above the pre-news close at day +5
Other Announcement 30 30.0% +20.8% +22.1% of 29 75.9% of 29
Clinical Trial Results 19 19.0% +19.8% +23.2% 89.5% of 19
Earnings 14 14.0% +16.8% +24.3% 100.0% of 14
M&A / Acquisition 10 10.0% +20.3% +16.2% 80.0% of 10
FDA & Regulatory 8 8.0% Fewer than 10 events in this group, so no figures are shown.

The day +5 figures are measured over the events in each group that have a five-session close, the count printed beside them, not over every event in the group.

6 other catalyst types, 19 events: Contract / Partnership, Buyback / Dividend, Offering / Dilution, Leadership Change, Reverse Merger / Shell, Crypto & Treasury.

How much of the move survived

Horizon Still above the pre-news close close to close Median change since the measured close as a share of the move
Day +1 97.0% of 99 1.9% given back, of 99
Day +5 86.9% of 99 2.0% given back, of 99
Month end 82.1% of 95 29.3% given back, of 95
Month end falls before day +5 for 22 of these 95 events, so this row is not a later horizon than the one above it. 95 of the 100 events have a month-end close later than the measured session; 4 have it on the measured session itself, and 1 has no month-end close.

Both figures in a row are measured over the events that have a close at that horizon, the count printed beside each of them, not over all 100 events on this board, which is why the denominators differ between rows.

Repeat runners

Some companies move on news more than once. The left list holds the ones that moved twice or more this month; the right list holds the ones that also moved in the months before it. The ranking above shows one row per move, so a name that keeps coming back is only visible here.

Moved twice or more inside September 2022

Two or more ranked moves this month, each on a different trading day.

SymbolMeasured sessionsBest move
SPRO 3Contract / Partnership, Other Announcement +167.74%
HROW 2FDA & Regulatory, Other Announcement +27.86%
ASAN 2Offering / Dilution, Other Announcement +24.79%
USEA 2Buyback / Dividend +17.36%
RGLS 2Clinical Trial Results, Other Announcement +15.48%

Also risen on news in earlier months

Ranked in at least two of the three months before this one. They are listed whether or not they rank this month, which is why the months are named.

SymbolMonthsBest move
RGS 2022-08, 2022-06 +75.15%
RMO 2022-08, 2022-06 +30.82%
RYTMthis month too 2022-08, 2022-07 +42.22%
GROVthis month too 2022-07, 2022-06 +84.25%
TRHC 2022-07, 2022-06 +56.54%
TNXP 2022-07, 2022-06 +45.38%
KRBP 2022-07, 2022-06 +79.22%
SIDUthis month too 2022-07, 2022-06 +225.00%
QD 2022-07, 2022-06 +40.34%
OCFT 2022-07, 2022-06 +21.21%

What the board was made of

Price before the move

Price bands are not shown on months older than a year, because the stored prices are adjusted for splits done since and a company that has reverse-split lands in a band its shares never traded in.

When the announcement landed

  • Pre-market70.0%
  • Intraday6.0%
  • After hours24.0%

Volume against normal

  • Under 5x31 events, 31.0%
  • 5x to 20x31 events, 31.0%
  • Over 20x38 events, 38.0%

Industry

  • Pharmaceutical Preparations26 events, 26.0%
  • Biological Products, (no Diagnostic Substances)5 events, 5.0%
  • Services-prepackaged Software5 events, 5.0%
  • Services-health Services3 events, 3.0%
  • Aircraft2 events, 2.0%
  • Biological Products, (no Disgnostic Substances)2 events, 2.0%

18 other industries, 22 events

Industry not known: 35.0%

Against August 2022

100 events in the comparable window.

August 2022 median +33.0%, selected from the 9,713 events in that month's eligible pool

September 2022 median +19.8%, 13.2 points below August 2022. September 2022's median is taken over the 100 ranked rows, selected from the 7,653 events in that month's eligible pool.

The two windows drew on pools of very different size, so part of the gap between the medians is how deep into each pool the top hundred reaches rather than how severe the moves were.

How this ranking is measured

Close-to-close change on the measured trading session, against the previous close.

  • An announcement before 16:00 ET is measured on that trading day; one at or after 16:00 ET, or on a weekend, is measured on the next trading day.
  • One row per company and measured session. Other announcements the company made in the same session are listed inside the row.
  • A ranking is a coincidence of news and price on the same session, not proof that the news caused the move. Part of an intraday move can precede the announcement.
  • No Stated Cause marks a release in which the company itself says it knows of no reason for the move, while Other Announcement marks a release these rules could not classify.

Eligibility uses each company's capitalization today, not its capitalization at the time. Archive boards can therefore change as companies grow or shrink.

Prices are adjusted for stock splits the company has done since, so an older row's dollar figures are stated on today's share count and are not the prices that traded that day. The percentage move, the dollar volume and the relative volume are unaffected, because both prices carry the same adjustment. The session's share count carries the adjustment too, so the shares figure beside the dollar volume is that count restated on today's basis rather than the number of shares that changed hands. Where the ticker was retired the price series stops with it and no later adjustment reached it, so those rows are marked as traded and their dollars are the ones that changed hands on the day.

Market cap is not shown on months older than a year, because only today's figure exists.

NYSE and Nasdaq companies with a market capitalization of $25M or more, measured today. The exchange is the one recorded on each announcement, and a release naming several tickers records one venue for all of them. A session that changed hands for less than $25,000 in total is not ranked, because a percentage set by a handful of shares is a print rather than a move. On a board older than a year a fund is identified by its name alone, because an instrument class describes whoever holds the ticker today.

On 100 of these rows the measured session was reconstructed from the announcement time, because it predates our stored session records.

This archive starts at 2020-04, the first month with ranked moves.